New Strategies in Myeloproliferative Neoplasms: The Evolving Genetic and Therapeutic Landscape

Por Patel, Ami B., Vellore, Nadeem A., Deininger, Michael W.
Publicado no Clin Cancer Res (2016)

Disarming an electrophilic warhead: Retaining potency in Tyrosine Kinase Inhibitor (TKI)-resistant CML lines, while circumventing pharmacokinetic liabilities

Por Ali, Ahmed M., Gómez-Biagi, Rodolfo F., Rosa, David A., Lai, Ping-Shan, Heaton, William L., Park, JiSung, Eiring, Anna M., Vellore, Nadeem A., de Araujo, Elvin D., Ball, Dan P., Shouksmith, Andrew E., Patel, Ami B., Deininger, Michael W., O’Hare, Thomas, Gunning, Patrick T.
Publicado no ChemMedChem (2016)